Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew D Snape

Showing results (51-60 of 169) with videos related to

Pageof 17
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2006
Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunizationMatthew D Snape, Dominic F Kelly, Penny Salt, et al.
The Pediatric Infectious Disease Journal|March 30, 2013
Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United KingdomGeraldine Blanchard-Rohner, Matthew D Snape, Dominic F Kelly, et al.
Immunology|January 30, 2009
Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccineDominic F Kelly, Matthew D Snape, Kirsten P Perrett, et al.
Vaccine|December 29, 2016
Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancyDavid Pace, Ameneh Khatami, Simon Attard-Montalto, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 25, 2015
Persistence of specific bactericidal antibodies at 5 years of age after vaccination against serogroup B meningococcus in infancy and at 40 monthsFiona McQuaid, Matthew D Snape, Tessa M John, et al.
The Pediatric Infectious Disease Journal|April 12, 2014
Persistence of bactericidal antibodies to 5 years of age after immunization with serogroup B meningococcal vaccines at 6, 8, 12 and 40 months of ageFiona McQuaid, Matthew D Snape, Tessa M John, et al.
The Pediatric Infectious Disease Journal|September 17, 2010
Persistence of immunity following a booster dose of Haemophilus influenzae type B-Meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trialAmeneh Khatami, Matthew D Snape, Tessa John, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 25, 2013
Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster doseMatthew D Snape, Praveen Saroey, Tessa M John, et al.
The Pediatric Infectious Disease Journal|December 8, 2022
A Randomized Trial Assessing the Immunogenicity and Reactogenicity of Two Hexavalent Infant Vaccines Concomitantly Administered With Group B Meningococcal VaccineMatthew Rajan, Natalie Marchevsky, Gemma Sinclair, et al.
Clinical and Vaccine Immunology : CVI|June 27, 2014
Randomized clinical trial to evaluate the immunogenicity of quadrivalent meningococcal conjugate and polysaccharide vaccines in adults in the United kingdomMaheshi N Ramasamy, Elizabeth A Clutterbuck, Kathryn Haworth, et al.
Pageof 17

Showing results (51-60 of 169) with videos related to

Sort By:
Pageof 17
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2006
Serogroup C meningococcal glycoconjugate vaccine in adolescents: persistence of bactericidal antibodies and kinetics of the immune response to a booster vaccine more than 3 years after immunizationMatthew D Snape, Dominic F Kelly, Penny Salt, et al.
The Pediatric Infectious Disease Journal|March 30, 2013
Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United KingdomGeraldine Blanchard-Rohner, Matthew D Snape, Dominic F Kelly, et al.
Immunology|January 30, 2009
Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccineDominic F Kelly, Matthew D Snape, Kirsten P Perrett, et al.
Vaccine|December 29, 2016
Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancyDavid Pace, Ameneh Khatami, Simon Attard-Montalto, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 25, 2015
Persistence of specific bactericidal antibodies at 5 years of age after vaccination against serogroup B meningococcus in infancy and at 40 monthsFiona McQuaid, Matthew D Snape, Tessa M John, et al.
The Pediatric Infectious Disease Journal|April 12, 2014
Persistence of bactericidal antibodies to 5 years of age after immunization with serogroup B meningococcal vaccines at 6, 8, 12 and 40 months of ageFiona McQuaid, Matthew D Snape, Tessa M John, et al.
The Pediatric Infectious Disease Journal|September 17, 2010
Persistence of immunity following a booster dose of Haemophilus influenzae type B-Meningococcal serogroup C glycoconjugate vaccine: follow-up of a randomized controlled trialAmeneh Khatami, Matthew D Snape, Tessa John, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|September 25, 2013
Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster doseMatthew D Snape, Praveen Saroey, Tessa M John, et al.
The Pediatric Infectious Disease Journal|December 8, 2022
A Randomized Trial Assessing the Immunogenicity and Reactogenicity of Two Hexavalent Infant Vaccines Concomitantly Administered With Group B Meningococcal VaccineMatthew Rajan, Natalie Marchevsky, Gemma Sinclair, et al.
Clinical and Vaccine Immunology : CVI|June 27, 2014
Randomized clinical trial to evaluate the immunogenicity of quadrivalent meningococcal conjugate and polysaccharide vaccines in adults in the United kingdomMaheshi N Ramasamy, Elizabeth A Clutterbuck, Kathryn Haworth, et al.
Pageof 17